RPS6KB1 and astrocytoma (excluding glioblastoma): Previous studies on astrocytomas [32], gastric cancer [30] and esophageal squamous cell carcinoma [33] also identified the phosphorylated RPS6KB1, but not total RPS6KB1, as a novel unfavorable prognosis indicator.